Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.

Cells - 8 Aug 2020

Rangel-Pozzo Aline, Liu Songyan, Wajnberg Gabriel, Wang Xuemei, Ouellette Rodney J, Hicks Geoffrey G, Drachenberg Darrel, Mai Sabine

Abstract excerpt

Accurate risk classification of men with localized high-risk prostate cancer directly affects treatment management decisions and patient outcomes. A wide range of risk assessments and classifications are available. However, each one has significant limitations to distinguish between indolent and aggressive prostate cancers. Circulating tumor cells (CTCs) may provide an alternate additional source, beyond tissue...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Copy Number Variations

Share to Genomics

Share to Neoplasm Staging

Share to Neoplastic Cells, Circulating

Share to Prostatic Neoplasms

Share to Single-Cell Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 32784507
DOI: 10.3390/cells9081863
PMCID: PMC7466090

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.PMID 32784507Read ↗

A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.Semantic proximity Read ↗

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancerSemantic proximity Read ↗

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing.Semantic proximity Read ↗

Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate CancerSemantic proximity Read ↗

An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate CancerSemantic proximity Read ↗

Single-cell genomic analysis of cancer cells from one treatment-naïve patient with metastatic prostate cancer.Semantic proximity Read ↗

Future directions for precision oncology in prostate cancerSemantic proximity Read ↗

High-Resolution Genomic Profiling of Disseminated Tumor Cells in Prostate Cancer.Semantic proximity Read ↗

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer.Semantic proximity Read ↗

Integrative genomic and epigenomic profiling in plasma and urinary cell-free DNA improves early risk stratification of newly diagnosed prostate cancerSemantic proximity Read ↗

Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissection.Semantic proximity Read ↗

Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.